Rademics Logo

Rademics Research Institute

Peer Reviewed Chapter
Chapter Name : Application of AI algorithms in the monitoring and management of cardiac implantable devices

Author Name : Shobana D, J. Gladys Aani Sujitha, V.Samuthira Pandi

Copyright: ©2025 | Pages: 36

DOI: 10.71443/9789349552975-08

Received: 05/10/20245 Accepted: 06/12/2024 Published: 12/03/202

Abstract

The integration of artificial intelligence (AI) with cardiac implantable electronic devices (CIEDs) has revolutionized remote monitoring, predictive diagnostics, and personalized patient care. Traditional device management relies on periodic clinical evaluations, which may lead to delayed detection of malfunctions or performance degradation. AI-driven analytics, in combination with Internet of Things (IoT) and cloud computing, enable real-time assessment of electrophysiological signals, device telemetry, and patient-specific risk factors. Machine learning and deep learning models enhance the accuracy of anomaly detection, reducing false positives and false negatives in ECG interpretation. Hybrid AI frameworks combining rule-based and neural network architectures improve predictive maintenance, ensuring timely interventions and extending device longevity. Blockchain technology strengthens data security by establishing a decentralized, immutable ledger for managing sensitive patient information and device performance metrics. The integration of AI, IoT, and blockchain in cardiac device monitoring fosters a secure, transparent, and efficient healthcare ecosystem, minimizing clinical workload while optimizing patient outcomes. This chapter explores advanced AI methodologies, predictive analytics, and cybersecurity frameworks that enhance the reliability, efficiency, and security of AI-enabled cardiac device management. Future advancements in AI-driven diagnostics and regulatory considerations will be critical in achieving widespread clinical adoption of intelligent cardiac monitoring systems.  

Introduction

The integration of artificial intelligence (AI) in the monitoring and management of cardiac implantable electronic devices (CIEDs) has revolutionized modern cardiovascular healthcare [1]. Traditional monitoring methods rely on periodic in-clinic evaluations, which often result in delayed detection of device malfunctions, arrhythmias, or battery depletion [2]. AI-driven remote monitoring enables real-time analysis of electrophysiological signals, facilitating early detection of abnormalities and improving patient outcomes [3]. By leveraging advanced machine learning and deep learning techniques, AI enhances the accuracy of predictive diagnostics, reducing the likelihood of missed anomalies and unnecessary clinical visits [4]. The ability to continuously monitor device performance and patient physiological data provides clinicians with valuable insights, enabling personalized treatment strategies and timely interventions for individuals with pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices [5]. 

Remote monitoring of cardiac implants generates vast amounts of data, which AI algorithms can process efficiently to identify patterns and predict potential complications [6]. Unlike traditional rule-based monitoring systems, AI-driven models continuously learn from historical and real-time data, refining their predictive capabilities over time [7]. Deep learning architectures such as convolutional neural networks (CNNs) and recurrent neural networks (RNNs) have demonstrated significant potential in analyzing ECG signals and detecting arrhythmic events with high precision [8]. AI-based anomaly detection models can distinguish between true cardiac events and benign variations, thereby minimizing false alarms that contribute to unnecessary clinical interventions [9]. These advancements enhance the reliability of remote cardiac monitoring, allowing for a proactive approach in device management and patient care [10]. ÂÂÂÂÂ